Introduction {#s1}
============

Plants are a great concern for drug discovery exploration and a major source of our modern medicine. About 25% of modern medicines are derived from a plant source and merely 5-15% of plants have been investigated for their medicinal use ([@B40]). Nowadays, natural plants, herbal medicines, phytomedicines, and functional foods are extensively studied by scientists all over the world which resulted with the lucrative therapeutic potentials such as antidiabetic ([@B107]; [@B118]; [@B104]; [@B20]), anticancer ([@B123]; [@B124]), immunomodulating ([@B36]; [@B108]; [@B109]; [@B110]; [@B111]), antiobesity and lipid lowering ([@B58]; [@B107]), anti-inflammatory ([@B43]) and anti-bacterial ([@B149]) activies. Among the potential medicinal plants, *Gymnema sylvestre*, belongs to the family of Apocynaceae, and is traditionally used for the treatment of various dieseases. It is a wild herb found in India, Africa, Australia, and China ([@B24]). It is known as Meshashringi, Merasingi, Kavali, Kalikardori, Vakundi, Dhuleti, Mardashingi, Podapatri, Adigam, Cherukurinja, Sannagerasehambu, Chigengteng or Australian Cowplant, Waldschlinge in German, Periploca of the woods in English ([@B50]). This plant is also recognized as 'Gurmur', due to having sugar lowering property ([@B147]). *Gymnema sylvestre* was considered as one of the major botanicals to treat diabetes in the Ayurvedic system of medicine and also is included in Indian Pharmacopoeia as an anti-diabetic plant ([@B133]). As it is useful against major diseases such as cardiovascular diseases, asthma, cancer, diabetes and obesity, different formulation of this plant is found in a number of preparations such as tea bags, health tablets, and food supplements. In various studies, *Gymnema sylvestre* is reported to be effective against arthritis, diuretic, anemia, osteoporosis, hypercholesterolemia, cardiopathy, asthma, constipation, microbial infections, indigestion, and as an anti-inflammatory agent ([@B147]). Although this plant has been proven valuable through its numerous useful properties, not many studies especially clinical studies on this plant are available. We aim to extensively review the therapeutic potential and phytochemical compounds present in this plant based on the published reports so far.

Search Strategy and Terms Used {#s2}
==============================

A comprehensive, electronic search was conducted for studies published before April 2019 using PubMed, SCOPUS, Web of Science, EMBASE, Elsevier, ScienceDirect, Researchgate, Google, and Google Scholar databases. Keywords related to, \`Pharmacology', 'Antioxidant', 'Anti-diabetic', 'Anticancer', 'Immunomodulatory', 'Anti-arthritis', Weight loss', 'Lipid lowering', 'Antimicrobial', 'Anti-inflammatory', 'Hepatoprotective', 'Gastroprotective', 'Traditional', 'Phytochemicals' combined with '*Gymnema sylvestre*' were used.

Botanical Description and Taxonomy of *Gymnema Sylvestre* {#s3}
=========================================================

*Gymnema sylvestre* (Retz.) R.Br. ex Sm. is a vulnerable and slow growing species. It appears as highly branched, woody and can climb up to the top of the tree that grows in the dry forests of central and southern India and in other regions of Asia ([@B148]; [@B53]). This is a shrub of pubescent type which has young stems and branches ([@B50]). Its root system is of tap root type ([@B89]). Stems are cylindrical, branched, hard, twining, internodes terete, 0.7-17.2 cm long and 2 -10 mm in diameter ([@B89]; [@B98]). The leaves have distichous phyllotactic opposite arrangement pattern, are 2.5--6 cm long, usually ovate or elliptical and simple ([@B50]). Leaves are acute or shortly acuminate, have petioles of 1- to 2-cm long, are smooth above, with a rounded base, a densely velvety pubescent beneath, and ciliate along margins, especially on the nerves. Venation is of transverse and reticulate type with a marginal vein ([@B62]; [@B98]). Seeds are 1.3 cm long, flat with a thin marginal wing and narrowly ovoid-oblong ([@B22]; [@B62]). Flowers are small and yellow in color, in axillary and lateral umbel in cymes. Follicles are terete, lanceolate and of up to 3 inches in length ([@B50]). Calyx is 5-lobed, ovate, obtuse, ciliated where corolla is campanulated, yellow, 5-lobed ([@B98]). Flowering of the plant occurs during August to March. Propagation through seed is difficult due to a low viability of seeds and, thus, plantation of root cuttings in June and July or plantation of terminal cuttings in February and March is done as an alternative approach ([@B62]).

Gymnema sylvestre (Retz.) R.Br. ex Sm. is from *Gymnema* genus which belongs to *Apocynaceae* family. This genus has 49 other approved species which includes *Gymnema* acuminatum *Wall., Gymnema* brevifolium *Benth., Gymnema* chalmersii *Schltr., Gymnema* hirsutum Wight and Arn. etc. ([@B146]). The Taxonomy of the plant is presented in [**Table 1**](#T1){ref-type="table"}.

###### 

Taxonomy of *Gymnema sylvestre* ([@B63]).

  Kingdom         Plantae
  --------------- ------------------------------------------
  Subkingdom      Tracheobionta
  Superdivision   Spermatophyta
  Division        Magnoliophyta
  Class           Magnoliopsida
  Subclass        Asteridae
  Order           Gentianales
  Family          *Apocynaceae*
  Sub-family      *Asclepiadaceae*
  Genus           *Gymnema*
  Species         *Gymnema sylvestre* (Retz.) R.Br. ex Sm.

Traditional Uses {#s4}
================

*Gymnema sylvestre* is mentioned in Shushruta, an ancient book on medicine as a remedy for glycosuria and urinary disorder ([@B88]). It is a therapeutic herb having multiple potentials as mentioned in folk medicine, Ayurveda, and Homeopathic systems of medicine ([@B50]). Traditionally, it has been used to treat diabetes, malaria and snake bites as well as to treat diseases caused by phlegm and piles in the Ayurvedic system of medicine ([@B62]; [@B133]). In Ayurveda, the plant is prescribed for the treatment of dyspepsia, constipation, jaundice, hemorrhoids, renal and vesicle calculi, cardiopathy, asthma, bronchitis, amenorrhea, and leucoderma ([@B112]; Nadkarni, 1996; [@B8]; [@B84]). Furthermore, different parts of the plant such as the roots, stem, and leaves have been used as cardiotonic, digestive, diuretic, laxative, stimulant, stomachic, and uterine tonic in traditional medicine systems ([@B84]). Various parts of this plant are used by different tribes in India such as the Sahariya tribe of Madhya Pradesh, Junglee Irulas of Nilgiri hills, Kol tribe of Chhattisgarh, and the Nayaks of Karnataka, to treat mainly asthma, eye and gastric problems, parkinsonism, urinary problems, and diabetes ([@B22]; [@B8]; [@B97]).

Phytochemistry of *Gymnema Sylvestre* {#s5}
=====================================

Stems of *Gymnema sylvestre* were investigated using chromatographic techniques and were found to have several therapeutically important chemical compounds such as stigmasterol and triterpenoid saponin. Stigmasterol compounds have multiple therapeutic potentials including antidiabetic, hypoglycemic, antioxidant, anticancer activities. Triterpenoid saponins also exhibited anti-tumor, anti-fungal, hepatoprotective and antidiabetic potential in several studies ([@B85]; [@B57]; [@B35]; [@B78]). Gymnemic acids and gymnemasaponins are major chemical constituents of this plant and are classified as oleanane saponins. Oleanane and dammarane type of saponins are found in the leaves of *Gymnema sylvestre* ([@B61]). The leaves of this plant also have saponins, anthraquinones, cardiac glycosides etc. ([@B94]). Moreover, this plant was also observed to have tannin, quinones, flavonoids, and phenols. ([@B114]). The phytochemical compounds found in the analysis of *Gymnema sylvestre* is listed in [**Table 2**](#T2){ref-type="table"}.

###### 

Phytochemical constituents of *Gymnema sylvestre*.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Constituents             Classification                                                                                    Chemical Structure                                                                                                                                                                                References
  ------------------------ ------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Triterpene saponins      Gymnemic acids-acylated (tiglolyl,\                                                               ![](fphar-10-01223-g003.jpg)                                                                                                                                                                      ([@B76])
                           methylbutyroyl) derivatives of\                                                                                                                                                                                                                                                                     
                           deacylgymnemic acid (DAGA) which is a\                                                                                                                                                                                                                                                              
                           3-O-*β*-glucouronide of gymnemagenin (3*β*,\                                                                                                                                                                                                                                                        
                           16*β*, 21*β*, 22*α*, 23,\                                                                                                                                                                                                                                                                           
                           28-hexahydroxy-Olean-12-ene).                                                                                                                                                                                                                                                                       

  Oleanane Saponins        Gymnemic acids and gymnemasaponins                                                                ![](fphar-10-01223-g004.jpg)                                                                                                                                                                      ([@B151])

  Gymnemanol               3,*β*-16,*β*-22,\                                                                                 ![](fphar-10-01223-g005.jpg)                                                                                                                                                                      ([@B106])
                           *α*-23-28-pentahydroxyolean-12-ene                                                                                                                                                                                                                                                                  

  Dammarene Saponins       Gymnemoside A, B, C,D,E,F                                                                         ![](fphar-10-01223-g006.jpg)\                                                                                                                                                                     ([@B154]; [@B155])
                                                                                                                             ![](fphar-10-01223-g007.jpg)                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                               

  Gymmestrogenin           Pentahydroxytriterpene                                                                            ![](fphar-10-01223-g008.jpg)                                                                                                                                                                      ([@B155])

  Gurmarin                 A 35-Amino acid peptide with a molecular weight of 4209                                           \<1Glu- Gln- Cys- Val- 5Lys- Lys- Asp- Glu- Leu- 10Cys- Ile- Pro-Tyr- Tyr- 15Leu- Asp- Cys- Cys- Glu- 20Pro- Leu- Glu- Cys- Lys-25Lys- Val- Asn- Trp- Trp- 30Asp- His- Lys- Cys- Ile- 35Gly\>.\   ([@B44])
                                                                                                                             (Glu = pyroglutamic-acid)                                                                                                                                                                         

  Triterpenoid saponins\   3-O \[*β*-D-glucopyranosyl\                                                                       ![](fphar-10-01223-g009.jpg)\                                                                                                                                                                     (J-GLOBAL-Japan Science and Technology Agency, n.d.a; J-GLOBAL-Japan Science and Technology Agency, n.d.b; J-GLOBAL-Japan Science and Technology Agency, n.d.c; J-GLOBAL-Japan Science and Technology Agency, n.d.d)
  Gymnemasin A\            (1-3)-*β*-D-glucopyranosyl\]-22-O-tiglyol gymnemanol\                                             ![](fphar-10-01223-g010.jpg)                                                                                                                                                                      
  Gymnemasin B\            3-O-\[*β*-D-glucopyranosyl-(1-3)-*β*-D-glucuro- nopyranosyl\]-\                                                                                                                                                                                                                                     
  Gymnemasin C\            Gymnemanol\                                                                                                                                                                                                                                                                                         
  Gymnemasin D\            3-O-*β*-D-glucuronopyranosyl-22-O-tigloyl- gymnemanol\                                                                                                                                                                                                                                              
                           3-O-*β*-D-glucopyranosyl-gymnemanol                                                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                               

  Flavonol glycoside       Kaempferol 3-O-*β*-D-glucopyranosyl-(1-4)-*α*- L-rhamnopyranosyl-(1-6)- *β*-D-galactopyranoside   ![](fphar-10-01223-g011.jpg)                                                                                                                                                                      ([@B77])

  Sterols                  Stigmasterol                                                                                      ![](fphar-10-01223-g012.jpg)                                                                                                                                                                      ([@B97])

  Lupeol                                                                                                                     ![](fphar-10-01223-g013.jpg)                                                                                                                                                                      ([@B134])

  d-Quercitol                                                                                                                ![](fphar-10-01223-g014.jpg)                                                                                                                                                                      ([@B97])

  Parabin                                                                                                                    ![](fphar-10-01223-g015.jpg)                                                                                                                                                                      ([@B134])

                           Quercitol                                                                                         ![](fphar-10-01223-g016.jpg)                                                                                                                                                                      ([@B147]).

                           Conduritol A                                                                                      ![](fphar-10-01223-g017.jpg)                                                                                                                                                                      ([@B147]).
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*In Vitro* and *in Vivo* Pharmacological Activity Reports on *Gymnema Sylvestre* {#s6}
================================================================================

*In vitro* and *In vivo* investigation of the therapeutic importance of *Gymnema sylvestre* revealed multifarious pharmacological potentials including anti-cancer, immunosuppressive, gastro-protective, hypoglycemic, anti-inflammatory, anti-infectious, and most importantly anti-diabetic activities. The pharmacological activities of phytochemicals derived from *Gymnema sylvestre* have been presented in [**Figure 1**](#f1){ref-type="fig"} and its reports are summarized in [**Table 3**](#T3){ref-type="table"}.

![Phamacological activities of the constituents of *Gymnema sylvestre*.](fphar-10-01223-g001){#f1}

###### 

Summary of Pharmacological Effects of *Gymnema sylvestre*.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Gymnema sylvestre* Extract                                       Type of study                                                              Study Model                                                                                                                                                                                                                                     Activities                                                                                     References
  ----------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ---------------------
  Water                                                             *In vivo*                                                                  Alloxan induced diabetic and normal Male Wister albino rats                                                                                                                                                                                     Blood glucose level was reduced                                                                ([@B113]; [@B3])

  *In vitro*                                                                                                                                   • Anti- oxidant activity                                                                                                                                                                                                                        ([@B11])                                                                                       

  *In vivo*                                                         Albino Rats                                                                • Anti-allergic\                                                                                                                                                                                                                                                                                                                               
                                                                                                                                               • Anti-stress\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                               • Inhibition of aspirin-induced gastric ulcers                                                                                                                                                                                                                                                                                                 

  *In vitro*                                                        *Staphylococcus aureus and Staphylococcus epidermidis*,\                   • Antimicrobial activity against *Pseudomonas aeruginosa, Candida albicans, Klebsiella pneumoniae 1, Pseudomonas aeruginosa, Salmonella typhimurium 2, Escherichia coli, Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus*\   ([@B10])                                                                                       
                                                                    *Escherichia coli*,\                                                       • *Enterococcus faecalis* and *Staphylococcus epidermidis* were insensitive to the plant extract.                                                                                                                                                                                                                                              
                                                                    *Klebsiella pneumoniae 1, Klebsiella pneumoniae*\                                                                                                                                                                                                                                                                                                                                                                         
                                                                    *2, Pseudomonas aeruginosa, Salmonella typhimurium 1*,\                                                                                                                                                                                                                                                                                                                                                                   
                                                                    *Salmonella typhimurium 2, Shigella*\                                                                                                                                                                                                                                                                                                                                                                                     
                                                                    *Flexneri, Candida albicans*,\                                                                                                                                                                                                                                                                                                                                                                                            
                                                                    *Candida tropicalis*,\                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                    *Methicillin-resistant Staphylococcus*\                                                                                                                                                                                                                                                                                                                                                                                   
                                                                    *Aureus*                                                                                                                                                                                                                                                                                                                                                                                                                  

  Alcohol                                                           *In vivo*                                                                  Wister Rats                                                                                                                                                                                                                                     • Fat digestibility was decreased\                                                             ([@B126]; [@B127])\
                                                                                                                                                                                                                                                                                                                                                                                               • Excretion of neutral sterols and acid steroids into feces was increased\                     
                                                                                                                                                                                                                                                                                                                                                                                               • Decreased the total cholesterol and triglyceride levels in serum\                            
                                                                                                                                                                                                                                                                                                                                                                                               • The decrease in body weight\                                                                 
                                                                                                                                                                                                                                                                                                                                                                                               • Inhibition of fat accumulation                                                               

  Acetone                                                           --                                                                         Culex\                                                                                                                                                                                                                                          • Larvicidal Activity                                                                          ([@B31])
                                                                                                                                               tritaeniorhynchus Giles (Diptera: Culicidae)                                                                                                                                                                                                                                                                                                   

  Methanol                                                          --                                                                         Culex\                                                                                                                                                                                                                                          • Larvicidal Activity                                                                          ([@B31])
                                                                                                                                               tritaeniorhynchus Giles (Diptera: Culicidae)                                                                                                                                                                                                                                                                                                   

  *In vivo* and *In vitro*                                          Alloxan induced diabetic Wistar rats                                       • Increased the weight of the whole body, liver, pancreas\                                                                                                                                                                                      ([@B3])                                                                                        
                                                                                                                                               • Increased liver glycogen content\                                                                                                                                                                                                                                                                                                            
                                                                                                                                               • Regeneration of β-cells                                                                                                                                                                                                                                                                                                                      

  *In vitro*                                                        L6 myotubes and 3T3 L1 murine adipocyte\                                   • Enhanced GLUT-4 and PPAR-γ gene expressions\                                                                                                                                                                                                  ([@B69])                                                                                       
                                                                    cell line                                                                  • Enhanced expression of adiponectin and leptin                                                                                                                                                                                                                                                                                                

  *In vivo*                                                         Wister rats                                                                • Reduced blood glucose level\                                                                                                                                                                                                                  ([@B28])                                                                                       
                                                                                                                                               • Reduced triglyceride, cholesterol level\                                                                                                                                                                                                                                                                                                     
                                                                                                                                               • Lowered urea, creatinine level                                                                                                                                                                                                                                                                                                               

  Chloroform                                                        --                                                                         Culex\                                                                                                                                                                                                                                          • Larvicidal Activity                                                                          ([@B31]
                                                                                                                                               *tritaeniorhynchus Giles* (Diptera: Culicidae)                                                                                                                                                                                                                                                                                                 

  *In vitro*                                                        *B. subtilis, S. epidermis, E. faecalis, S. aureus*,\                      • Shown wide range of inhibitory activity against *Staphylococcus aureus* and *Klebsiella pneumoniae*                                                                                                                                           ([@B21])                                                                                       
                                                                    *P. aeruginosa, E. cloacae; E. aerogene; E. coli*,\                                                                                                                                                                                                                                                                                                                                                                       
                                                                    *S. typhimuriumand K. pneumoniae*                                                                                                                                                                                                                                                                                                                                                                                         

  OSA                                                               *In vitro*                                                                 MIN6 mouse β-cell and human islets of Langerhans                                                                                                                                                                                                • Increased insulin secretion                                                                  ([@B75])

  *In vivo*                                                         Insulin-resistant ob/ob mice                                               • Improved glucose-intolerant status                                                                                                                                                                                                            ([@B7])                                                                                        

  *In vitro*                                                        Isolated mouse islets                                                      • Increased insulin secretion                                                                                                                                                                                                                                                                                                                  

  *In vitro*                                                        Human Islets of Langerhans                                                 • Increase in Insulin Secretion                                                                                                                                                                                                                                                                                                                

  Gymnemic Acids extracted from *Gymnema sylvestre*                 *In vitro*                                                                 Male Hartley Guinea-pigs                                                                                                                                                                                                                        • Suppressive effect on the H-65 *K*^+^ induced contraction of the ileal longitudinal muscle   ([@B128])

  *In vitro*                                                        Guinea-pigs and Wister rats                                                • Suppression of glucose invoked transmural potential difference increase in the inverted intestines                                                                                                                                                                                                                                           

  *In vivo*                                                         Male Sprague-Dawley Strain Rats                                            • Suppression of Glucose level                                                                                                                                                                                                                                                                                                                 

  *In vivo*                                                         Male rats of the Wistar-ST strain                                          • Increased fecal cholesterol and CA-derived bile acid excretion                                                                                                                                                                                ([@B90])                                                                                       

  Ethanol Extract                                                   *In vivo*                                                                  Ulcerative\                                                                                                                                                                                                                                     • Suppressed oxidative and inflammatory response\                                              ([@B5])
                                                                                                                                               colitis induced Wister albino rats                                                                                                                                                                                                              • Protected colonic mucosal content                                                            

  *In vivo*                                                         Streptozotocin-induced diabetic Albino Rats                                • Establishes blood glucose homeostasis\                                                                                                                                                                                                        ([@B120])                                                                                      
                                                                                                                                               Brings glycoconjugate components to near normal levels                                                                                                                                                                                                                                                                                         

  *In vitro*                                                        Human skin melanoma cell line (A375) and normal liver cell line (WRL-68)   • Apoptotic effect on A375 cells                                                                                                                                                                                                                ([@B16])                                                                                       

  *In vivo*                                                         Female ICR mice                                                            • Showed inhibitory effects on TPA-induced inflammation                                                                                                                                                                                         ([@B150])                                                                                      

  *In vivo*                                                         Streptozotocin-induced diabetic Wistar albino rats                         • Reduction in the pain threshold\                                                                                                                                                                                                              ([@B32])                                                                                       
                                                                                                                                               Reduction in body weight\                                                                                                                                                                                                                                                                                                                      
                                                                                                                                               • Mitigation of blood glucose levels and increased insulin level\                                                                                                                                                                                                                                                                              
                                                                                                                                               • Attenuated the elevated levels of cytokines in the serum and sciatic tissues                                                                                                                                                                                                                                                                 

  *In vitro*                                                                                                                                   • exhibited strong antioxidant activity                                                                                                                                                                                                         ([@B52])                                                                                       

  *In vivo*                                                         Streptozotocin induced diabetic Sprague−Dawley male rats                   • Decreased the activity of glutathione peroxidase in cytosolic liver\                                                                                                                                                                          ([@B25])                                                                                       
                                                                                                                                               • Reduced glutamate pyruvate transaminase in serum to normal levels                                                                                                                                                                                                                                                                            

  *In vivo*                                                         Streptozotocin-induced diabetic Wister rats                                • Showed hypoglycemic and hypolipidemic activity                                                                                                                                                                                                                                                                                               

  Dihydroxy gymnemic triacetate isolated from *Gymnema sylvestre*   *In vitro*                                                                 Mouse pancreatic *β*-cell lines (MIN6)                                                                                                                                                                                                          • Inhibited yeast *α*-glucosidase, sucrase, maltase, and pancreatic *α*-amylase\               ([@B125])
                                                                                                                                                                                                                                                                                                                                                                                               • Increased insulin secretion\                                                                 
                                                                                                                                                                                                                                                                                                                                                                                               • Showed protection against H~2~O~2~ induced ROS generation                                    

  Isolated Triterpene Glycoside\                                    *In vitro*                                                                 Wister Rats                                                                                                                                                                                                                                     • Inhibited Glucose-Stimulated Gastric Inhibitory Peptide Secretion                            ([@B33])
  fraction from *Gymnema sylvestre*                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Antidiabetic Activity {#s6_1}
---------------------

The most widely known effect of *Gymnema sylvestre* is anti-diabetic activity. Ethanol extract of this plant is reported to reduce glucose level by 46% where the water extract reduced glucose level by 26% and methanol extract by 12% ([@B86]; [@B79]; [@B65]; [@B117]; [@B116]). In dexamethasone-induced insulin resistance rats, aqueous extract of this plant was found to be improving the altered glucose, insulin and lipid profile ([@B71]). Administration of this plant in a diabetic animal model resulted in reductions in the blood levels of insulin, protein, triglycerides, cholesterol, and glucose, as well as a reduction in body weight and was found to improve liver histopathology ([@B140]). In another study where alloxan-induced diabetic rats were used, this plant extract significantly (*p* \< 0.05) reduced fasting blood glucose level, total cholesterol, serum triglycerides and increase HDL-cholesterol level and is also described to significantly alter (*p* \< 0.05) the elevated level of urea, uric acid and creatinine levels in diabetic rats to nearly normal levels ([@B113]; [@B81]). *Gymnema sylvestre* reduced the level of blood glucose levels after both acute and chronic administration of methanolic extract of this plant on Wister rats ([@B28]). In the case of Streptozotocin-induced diabetic rats, it has been shown that treatment using this plant significantly (*p* \< 0.05) decreased the elevated blood glucose, ALT, AST, triglycerides, total cholesterol, LDL-cholesterol, and malondialdehyde, and significantly (*p* \< 0.05) increased insulin, HDL-cholesterol, and erythrocyte superoxide dismutase levels in diabetic rats and also is capable of regenerating insulin producing β-cells ([@B9]; [@B115]; [@B68]; [@B4]). Gymnemic acids (a type of triterpene saponin compounds) are the class of active constituents isolated form *Gymnema sylvestre*. It was found that gymnemic acid IV given at a dose of 3.4/13.4 mg/kg adaministered for 6 hours decreased blood glucose levels by 14.0--60.0% as compared to glibenclamide. Also, gymnemic acid IV increased plasma insulin levels in STZ-diabetic mice when administered at a concentration of 13.4 mg/kg ([@B139]). In a study, oral administration of small concentrations (0.2 g/kg) of this plant produced a reduction in the elevated levels of blood sugar induced by sucrose ([@B51]). However, [@B34] also informed an absence of anti-diabetic activity of *Gymnema sylvestre* in an alloxan treated animal model ([@B34]).

Mechanism of Action of *Gymnema Sylvestre* for Antidiabetic Activity {#s6_2}
--------------------------------------------------------------------

Several mechanisms have been proposed to explain the anti-diabetic activity of *Gymnema sylvestre* ([**Figure 2**](#f2){ref-type="fig"}). Gymnemic acids can prevent absorption of sugar molecules by the intestine, which leads to a reduction in blood sugar levels ([@B147]). One of the constituents of *Gymnema sylvestre* is gymnemic acid which is a mixture of saponins ([@B153]). The atomic arrangement of gymnemic acid molecules is similar to that of glucose molecules and it blocks the receptor site for sugar in the intestines, preventing the absorption of sugar which reduces blood sugar level ([@B106]). Rapid screening by Affinity Ultrafiltration-HPLC-MS shows that it contains α-glucosidase inhibitors ([@B19]). It is reported to increase the activity of enzymes which are insulin dependent including hexokinase, glycogen synthetase, glyceraldehydes 3-phosphate dehydrogenase, and glucose 6-phosphate dehydrogenase, and to decrease the activity of insulin-independent enzymes such as glycogen phosphorylase, gluconeogenic enzymes, glucose 6-phosphatase, fructose 1,6- diphosphatase, and sorbitol dehydrogenase, which also increases phosphorylase activity. *Gymnema sylvestre* was also found to increase the secretion of insulin and the possible role in regenerating insulin as well as β-cell was suggested ([@B121]; [@B90]; [@B9]). In a study, methanol extract of this plant showed increased effect on β-cell regeneration and was extrapolated that this plant might be able to completely recover pancreatic-cells function and thus treating type I diabetes ([@B3]).

![Mechanism of glucose lowering activity by *Gymnema sylvestre*.](fphar-10-01223-g002){#f2}

Anticancer Activity {#s6_3}
-------------------

*Gymnema sylvestre* was found to have anticancer activity in various investigations. Its constituent gymnemagenol (C30H50O4) showed positive anticancer activity against HeLa cells ([@B59]). The ethanolic, ethyl and chloroform extract were tested for anticancer activity against A549 (human lung adenocarcinoma) and MCF7 (human breast carcinsoma) cell lines. Theses extract revealed anticancer activity with a similar IC50 value against MCF cell lines where in the case of A549, ethyl and chloroform extract were more active than the ethanol extract ([@B136]). Ethanolic extract of *Gymnema sylvestre* showed anticancer activity in A375 cells (human skin melanoma). It showed cytotoxic activity against A375 cell and antitumor activity in skin Papilloma model where, in the case of normal liver cells WRL-68, it showed no cytotoxic activity ([@B16]). It was revealed to have significant (*p* \< 0.0001) inhibitory effect against intestinal breast cancer resistance protein (BCRP) ([@B144]). In a study, the administration of flavonoids was found to be inhibiting BCRP and subsequently, improving multi-drug resistance of BCRP substrates that was induced by it ([@B42]). Thus, it can be suggested that inhibition of this protein by *Gymnema sylvestre* may improve the activity of BCRP substrates methotrexate, daunorubicin, topotecan, epirubicin, flavopiridol, and so on by increasing systemic availability and absorption ([@B82]). Ethanolic extract of this plant exhibited antiproliferative effects in mice with two-stage carcinogenesis with a 50% inhibitory dose of 50--555 nmol/ear ([@B150]). Polysaccharides (GSP11, GSP22, GSP33, GSP44 and GSP55) isolated from *Gymnema sylvestre* was reported to have anticancer activity by improving immunological function through increasing phagocytic function, enhanced serum hemolysin levels, thymus, and spleen indexes. GSP11 and GSP33 showed inhibitory rates of 78.6% and 83.8%, respectively, against U937 cells and GSP22 showed activity against SGC cells with an inhibitory rate of 78.2%. ([@B148]). In another study, antitumor potential of this plant was observed when methanolic extract of *Gymnema sylvestre* was administered on Swiss albino mice where papillomagenesis was induced using carcinogen 7, 12 - dimethylbenz (a) anthracene (DMBA). Decreased tumor incidence, tumor burden and the cumulative number of papillomas were observed after the treatment with the plant extract ([@B1]).

Lipid-Lowering Activity {#s6_4}
-----------------------

*Gymnema sylvestre* leaf extract was observed to possess very potent hypolipidaemic activity. In a study, *Gymnema sylvestre* leaf extract was administered to Wister female rats. These rats were introduced to hyperlipidemia by high-fat diet. It was detected that this extract significantly lowered the level of cholesterol (*p\<* 0.01), low-density lipoprotein (LDL) (*p\<* 0.01), and triglyceride (*p\<* 0.01) as well as increased the level of high-density lipoprotein (HDL) (*p\<* 0.001) effectively ([@B131]). Furthermore, hydro-alcoholic leaf extract of *Gymnema sylvestre* was also observed to have lipid-lowering potential. In this study, rats were given high cholesterol for seven days and a higher level of cholesterol, triglyceride, LDL, and a lower level of HDL was observed. After seven days, these rats were treated with *Gymnema sylvestre* extract and it was reported to lower the elevated cholesterol, triglyceride, LDL level and increase the HDL level. It was suggested that this plant renders lipid-lowering potential due to the presence of acidic constituents such as flavonoids, saponins, tannins etc. ([@B101]; [@B28]). Similarly, in several other studies, it was reported to reduce triglyceride, cholesterol, very low‐density lipoprotein (VLDL) and low‐density lipoprotein (LDL) in diabetic rats ([@B14]; [@B73]).

Antimicrobial Activity {#s6_5}
----------------------

Different extracts and isolated bioactive compounds of *Gymnema sylvestre* were reported to have anti-microbial potential against several microorganisms. Methanolic extract of the leaves of this plant was reported to show antimicrobial activity against *E. coli, B. cereus, C*. albicans, and *C*. kefyr. The aqueous extract showed moderately anti-microbial activity against *S. aureus, C*. krusei, *C. perfringens* type-A and *C*. kefyr where the hexane extract showed activity against *S. aureus, B. cereus, S*. enterica, H. paragallinarum and *C. perfringens* type-A ([@B26]; [@B143]). Both aqueous and ethanol extract is active against pathogenic Salmonella species (*Salmonella typhi, S. Typhimurium*, and *S. paratyphi*). Ethanolic, chloroform, and ethyl acetate extracts were reported to be active against *P*. vulgaris, *E. coli, P*. aeroginosa, K. pneumoniae, and *S. aureus* ([@B93]; [@B95]). [@B141] observed that this plant was effective against several gram positive and negative bacteria such as *S. aureus, E. Coli, K. pneumoniae* and *P. aeruginosa*. In a study where antimicrobial activity was measured using a disk diffusion method, gymnemic acid, isolated from this plant, also showed antimicrobial activity against *E. coli, V. cholera, S. mutans, S. aureus, A. niger* and *C. albicans* with zone of inhibition of 8.65 mm, 6.00 mm, 7.12 mm, 9.25 mm, 6.43 mm and 8.60 mm, respectively ([@B38]). It has anti-microbial potential against a wide range of microorganisms including *E. coli, P. aeruginosa, B. subtilis, E. hirae, M. luteus, S. aureus* and *C. albicans* ([@B145]; [@B10]; [@B37]). Antibacterial activity of gymnemic acid, a triterpene saponin, isolated from *Gymnema sylvestre* was also studied against *E. coli* and *B. cereus* and it was found active against the microbes ([@B129]). Recently, antimicrobial properties of *Gymnema sylvestre* leaf extract have been enhanced using poly-ε-caprolactone nanofibers ([@B103]) or by using ZnO nanoparticles ([@B55]). *Gymnema sylvestre* with ZnO nanoparticles was found to be effective against gram positive *Staphylococcus aureus* and *Streptococcus pneumoniae* bacteria and gram negative *Klebsiella pneumoniae, Shigella dysenteriae, Escherichia coli, Pseudomonas aeruginosa* and *Proteus vulgaris* bacterial strains ([@B55]). Using poly-ε-caprolactone nanofibers with this plant was potently active against methicillin-resistant *Staphylococcus aureus, Staphylococcus aureus, Pseudomonas aeruginosa, Staphylococcus epidermidis and Escherichia coli* ([@B103]).

Antioxidant Activity {#s6_6}
--------------------

Ethanol extract of this plant revealed significant (*p* \< 0.05) 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity and showed better antioxidant potential than *A. bilimbi* and *C. frutescens* ([@B102]). Anti-oxidant activity of *Gymnema sylvestre* against DPPH was also observed in an investigation by [@B105]. This plant was found to have better DPPH radical scavenging than butylated hydroxyl toluene (BHT) and in another study it was also found to reduce LDL oxidation ([@B92]; [@B105]). Recently, in another study, hydroxyl free radical scavenging activity and significant antioxidative potential of this plant against DPPH was reported where DPPH inhibition was at the level of 87.3% and hydroxyl free radical inhibition was 59.8% ([@B37]). It was also found to have significant radical scavenging activity against ferric (*p* \< 0.05), super oxide (*p* \< 0.05) and also against hydrogen peroxide (*p* \< 0.05) ([@B100]). *Gymnema sylvestre* showed antioxidant activity in several conditions such as against high fat diets, hydrogen peroxide, nitric oxide, and superoxide radically induced oxidative stress in rats ([@B11]; [@B64]; [@B17]).

Antiarthritic Activity {#s6_7}
----------------------

Aqueous and petroleum extract of *Gymnema sylvestre* revealed significant (*p* \< 0.01) antiarthritic activity ([@B80]). It was suggested that *Gymnema sylvestre* may have reduced the release of inflammatory mediators which is necessary to reduce bone destruction in anti-arthritic condition ([@B80]). In another study, ethanolic extract of the root of *Gymnema sylvestre* reduced carrageenan rat paw oedema significantly (*p* \< 0.01) and inhibited 39-75% of histamine induced rat paw oedema ([@B119])

Immunomodulating Activity {#s6_8}
-------------------------

Methanolic leaf extract of *Gymnema sylvestre* (MLEGS) showed immunosuppressive activity in Swiss Albino mice when it was tested by performing hemagglutination antibody (HA) titer, delayed-type hypersensitivity (DTH) tests and flow cytometric techniques for the estimation of B lymphocytes (CD3 and CD19) and Th2 cytokines (IL-2, IFN-γ and IL-4). This plant significantly reduced primary and secondary antibody response and DTH response in a dose-related manner. At 200 mg/kg body weight, the maximal reductions occurred in the production of CD3, CD19, IL-2, IFN-γ and IL-4 at the level of 31.59, 32.12, 29.51, 32.45 and 33.53%, respectively ([@B2]). However, it was also perceived that *Gymnema sylvestre* enhances the level of myeloid and lymphoid components of the immune system. Methanolic extract of this plant significantly increased (*p* \< 0.05) the stimulation of Nitric oxide (NO) and Reactive Oxygen Species (ROS) by stimulation of macrophage activity and, also, significantly (*p* \< 0.05) reduced nitroblue tetrazolium ([@B132]). Aqueous extract of *Gymnema sylvestre* also stimulated the phagocytic function of human neutrophils suggesting an immunostimulatory activity ([@B49]). Ethanol extract of this plant was observed to improve immunosuppressed condition induced by cyclophosphamide in Albino Rats. In this study, the plant extract significantly improved haemagglutination titer, phagocytic activity and decreased paw edema (*p* \< 0.01, *p* \< 0.05 and *p* \< 0.05 respectively), when compared with cyclophosphamide treated control ([@B54]). In another study, potent immunostimulatory potential of the aqueous extract of this plant was observed ([@B39]).

Anti-Inflammatory Activity {#s6_9}
--------------------------

Methanoic extract of Gymnema sylvestre showed anti-inflammatory activity in Wistar rats where carrageenan-induced inflammation was introduced in the rats. Methanolic extract of this plant reduced carrageenan-induced rat paw edema significantly (*p* \< 0.05) ([@B67]). In another study, aqueous extract of this plant displayed inhibitory potential against carrageenan-induced rat paw edema and peritoneal ascites in mice ([@B29]). Furthermore, ethanolic extract of this plant was reported to show inhibitory effects against TPA-induced inflammation, with a 50% inhibitory dose of 50--555 nmol/ear where *In vivo* two-stage carcinogenesis was introduced in mice using 7,12-dimethylbenz\[a\]anthracene as an initiator and 12-O-tetradecanoyl phorbol-13-acetate (TPA) as a promoter ([@B150]).

Effect on Gastrointestinal Tract {#s6_10}
--------------------------------

Methanolic extract of Gymnema sylvestre showed anti-ulcer activity in pylorus ligated Wister rat, forced swim stress-induced ulcer model as well as in rats where ulcer was induced by Indomethacin. It reduced the ulcer index significantly (*p* \< 0.01) and also reduced free acidity, total acidity and gastric volume, and increased the pH of gastric juice. It was suggested that anti-ulcer activity was due to the presence of phytochemical constituents such as saponins, flavanoids, tannins, sterols, glycosides, alkaloids, resins, carbohydrates, proteins, triterpenoids ([@B142]). A herbomineral formulation containing *Gymnema sylvestre* was found to improve impaired gastric emptying and intestinal transit associated with diabetes. In this study, *Gymnema sylvestre* containing formulation was found to significantly restore gastric emptying time and intestinal transit (*p* \< 0.001 and *p* \< 0.001 respectively), ([@B135]). However, *Gymnema sylvestre* was also shown to inhibit Glucose-Stimulated Gastric Inhibitory Peptide Secretion in Wister Rats significantly (*p* \< 0.05) ([@B33]). Ethanolic extract of the leaves was described to improve mucosal injury induced by ethanol in Wister Albino rats. In this study it was observed that treatment of rats with this plant extract resulted in a significant depletion of stomach-wall mucus (*p* \< 0.001), total proteins (*p* \< 0.01), nucleic acids (*p* \< 0.001), and non-protein sulfhydryl groups (*p* \< 0.001) ([@B6]). In a study, where gastric ulcer was induced in Swiss Albino male mice, aqueous extract of this plant was reported to show anti-ulcerative properties where it was observed that treatment with the plant extract exhibited significant (*p* \< 0.05) protective activity against aspirin induced ulcer in rat models ([@B11]).

Hepatoprotective Activity {#s6_11}
-------------------------

In an in-vitro investigation, hydro-alcoholic extract of *Gymnema sylvestre* was observed to render anti-hepatotoxic function in a dose-dependent manner in isolated rat hepatocytes where hepatotoxicity was induced using D -- galactosamine. A significant increase in the level of ASAT, ALAT, ALP, total bilirubin and direct bilirubin (*p* \< 0.001) was observed ([@B138]). It was reported to lower urea and creatinine levels after acute and chronic administration of methanolic extract of this plant in Wister rats ([@B28]). In a study where methanolic poly herbal preparation containing this plant was used, it was observed that the preparation can reverse hepatotoxicity in Albino rats induced by paraffin and carbon tetrachloride ([@B152]).

Effect on Body Weight {#s6_12}
---------------------

Ethanol extract of this plant was found to reduce body weight in Wister rats ([@B126]). Similarly, when Streptozotocin-induced diabetic Albino rats were treated with ethanolic extract of Gymnema syvestre, a significant (*p* \< 0.001) weight reduction was also observed ([@B32]). However, in a different study, ethanol extract of this plant was reported to cause increase in the weight of the whole body, liver, pancreas in alloxan induced diabetic Wistar rats ([@B3]).

Anticaries Activity {#s6_13}
-------------------

The methanol extract of *Gymnema sylvestre* disclosed antimicrobial activity against *Streptococcus* mutans which is responsible for the formation of dental caries ([@B27]). Gymnema Acid from this plant can reduce glucan as well as plaque formation by *Streptococcus mutants* ([@B96]).

Clinical Study Reports of *Gymnema Sylvestre* {#s7}
=============================================

Apart from various investigations on animal models, different extracts of this plant were tested on humans to inspect its therapeutic potential on the human body. Clinical investigations on *Gymnema sylvestre* revealed its potential to reduce body weight and glucose levels, triglyceride, LDL-c, total cholesterol and elevate the amount of insulin and C-peptide available in blood. A study conducted on 58 patients with type 2 diabetes mellitus for 90 days resulted in the reduction of fasting (p \< 0.005) and post prandial blood glucose levels (p \< 0.001) along with a reduction of triglyceride (*p* \< 0.05) ([**Table 4**](#T4){ref-type="table"}) ([@B70]). In another study, where 64 individuals with type 1 diabetes were treated with Gymnema leaf extract for 6 to 30 months resulted with the reduction of plasma glucose level, reduced external insulin dose and significant reduction in HbA1c (*p* \< 0.001) ([@B122]). Significant (*p* \< 0.05) reduction in blood glucose level was observed in another study where 32 human subjects with type-2 diabetes were administered with *Gymnema sylvestre* leaf powder in hard gelatin capsule for 30 days. Reduction in triglyceride, cholesterol and LDL level was also observed in this study ([@B74]) ([**Table 4**](#T4){ref-type="table"}). The therapeutic potential of *Gymnema sylvestre* (GS) observed from clinical studies so far conducted has been summarized in [**Table 4**](#T4){ref-type="table"}.

###### 

Summary of clinical study results on *Gymnema sylvestre*.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Preparation of the plant given                                                   Number of subjects                       Duration         Therapeutic potential                                                                                                   Reference
  -------------------------------------------------------------------------------- ---------------------------------------- ---------------- ----------------------------------------------------------------------------------------------------------------------- -----------
  OSA (Novel high molecular weight GS preparation)                                 11                                       60 days          • Significant reduction in fasting and post-prandial blood glucose level (*p* \< 0.005 and *p* \< 0.02 respectively)\   ([@B7])
                                                                                                                                             • Significantly increased level of insulin and C-peptide in blood (*p* \< 0.05 and *p* \< 0.001, respectively)          

  Extract of leaves in capsule form                                                58 human subjects with type-2 diabetes   90 days          • Reduction in hyperglycemia and hypertriglyceridemia (*p* \< 0.05)\                                                    ([@B70])
                                                                                                                                             • Reduced fasting and post-prandial blood glucose levels significantly (*p* \< 0.005 and *p* \< 0.001, respectively)\   
                                                                                                                                             • Significantly increased HbA1c level ( *p* \< 0.001)\                                                                  
                                                                                                                                             • Significantly reduced insulin resistance (*p*\< 0.05)                                                                 

  GS leaf powder in hard gelatin capsule                                           32 human subjects with type-2 diabetes   30 days          • Significantly reduced glucose level (*p* \< 0.05)\                                                                    ([@B74])
                                                                                                                                             • Reduced triglyceride, cholesterol and LDL level                                                                       

  Aqueous GS leaf extract                                                          8 healthy participants                   90 min           • Reduced oral sweet taste sensation significantly (*p* \< 0.05)\                                                       ([@B56])
                                                                                                                                             • Reduced blood glucose level                                                                                           

  Ethanol extract of GS leaves                                                     22 type 2 diabetic patient               18-20 months     • Reduced glucose level significantly (*p* \< 0.001)\                                                                   ([@B12])
                                                                                                                                             • Elevated serum insulin in both the fasting and post-prandial state                                                    

  Leaf extract of GS                                                               64 individuals with type\                6 to 30 months   • HbA1c level was reduced significantly (*p* \< 0.001)\                                                                 ([@B122])
                                                                                   1 diabetes                                                • Reduced glucose level\                                                                                                
                                                                                                                                             • Reduced requirement of Insulin                                                                                        

  *G. sylvestre* (Swanson Premium *G*.\                                            24 diabetic patients                     12 weeks         • Reduction in body weight, body mass index (BMI) significantly (*p* \< 0.05 and *p* \< 0.05, respectively)\            ([@B156])
  *sylvestre* leaf; Swanson Health Products, Fargo, ND, USA)                                                                                 • Decreased level of very low-density lipoprotein (VLDL) significantly (*p* \< 0.05)                                    

  Calcium-potassium salt of (-)-hydroxycitric acid, niacin-bound chromium and GS   90 obese subjects                        8 weeks          • Reduced weight                                                                                                        ([@B99])

  Drops of GS "Q" with\                                                            21 people type 2 diabetes                6 months         • Controlled blood glucose level                                                                                        ([@B66])
  1/4 cup of water                                                                                                                                                                                                                                                   

  Aqueous decoction of shade-dried powdered leaves of GS                           10 healthy and 6 diabetic adults         10 days          • Reduced blood glucose level                                                                                           ([@B60])
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Toxicological Reports on *Gymnema Sylvestre* {#s8}
============================================

Toxicology study on Albino mice treated with Gymnema sylvestre showed LD50 level at 3990 mg/kg and the safety ratio for normal and diabetic mice was found to be 11.08 and 16.03 respectively. In this study, no behavioral, neurologic and autonomic adverse effects were observed ([@B18]). Another study reported LD50 of ethanol and water extract of *Gymnema sylvestre* to be 375mg/kg where mice were treated by intraperitoneal route with the plant extract ([@B13]). One case of drug-induced liver injury (DILI) was informed in the case of a patient who was treated with *Gymnema sylvestre* for diabetes mellitus ([@B130]). It was stated that this plant can cause hypoglycemia in both diabetic and non-diabetic patient ([@B60]) and in the case of the diabetic animal model, one study reported persistent hypoglycemic effect even after the treatment with Gymnema sylvestre was stopped ([@B137]). However, no toxic effects were observed in a study where male and female Wistar rats were treated with *Gymnema sylvestre* for 52 weeks ([@B91]).

Use of *Gymnema Sylvestre* as Dietary Supplement {#s9}
================================================

Concerning the use of extract of *Gymnema sylvestre* as a dietary supplement in Europe, the European Food Safety Agency recognizes the property of this plant which maintains normal sugar levels in organisms and in their conditions of use it must contain 400- 800 mg of gymnema extract, equal to 100- 200 mg kgymnemic acid (EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010).

Presently, there are considerable knowledge gaps for the risk assessment of *G. sylvestre* preparations and open questions for whether results obtained with one preparation can be extrapolated to another Gymnema preparation. Also, based on the lack of systematic data on dose and effect relationships, the available information was regarded as not being sufficient for the derivation of health-based guidance values for Gymnema or Gymnema preparations. Considering the uncertainties for the composition of different Gymnema preparations, potential herb--drug interactions and the concerns about glucose lowering or hypoglycaemic effects, the use of Gymnema-based food supplements in combination with (or as a substitute for) authorized antidiabetic drugs may be associated with risks when used without medical supervision ([@B83]).

Summary and Future Perspectives {#s10}
===============================

Phytochemicals account for numerous pharmacological properties. They are observed to have anti-metastatic, anti-diabetic, hypoglycemic, anti-oxidant, hepatoprotective, anti-inflammation, anti-bacterial, anti-fungal, anti-viral etc. activities. Plants contain compounds such as flavonoids, alkaloids, and tannins that render these life-saving therapeutic activities. It has been reported that about 80% of people from developing countries rely on natural medicines for the treatment of diseases and their primary health concerns ([@B41]). However, despite having great demand and therapeutic uses only 10% of the plants have been investigated for their therapeutic potential ([@B72]). Furthermore, some of these plants which could be a great source of biologically important novel phytoconstituents are on the verge of extinction due to unsustainable use, destruction of forests, and habitat destruction ([@B15]). One of these therapeutically important plants that contain significant biologically important phytochemicals is *Gymnema sylvestre*. It constitutes saponins, flavonol, glycosides, gymnemanol, gurmarin etc. These phytochemicals isolated from *Gymnema sylvestre* can provide pharmacological activities such as anti-diabetic, anti-oxidative, anti-metastatic, anti-inflammatory, lipid-lowering and several other properties.

However, this plant is also subject to unsustainable use. It is disappearing very fast due to overexploitation and extensive collection to meet the demand ([@B23]). Many unauthorized preparations of this plant are found in the local market. People are using this plant as a cheap substitution for their anti-diabetic medicine without any knowledge of what part of the plant to be used which results in unnecessary destruction the whole plant. Thus, this plant is being wasted without being used up to their maximum potential. In order to prevent the waste of this plant, legal production of medicinal preparation from the plant should be ensured and sustainable use of this plant should be closely monitored. In addition to these, people should be also made aware of the proper use of the plant so that they can get maximum benefit from this plant.
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